Ulixacaltamide is a highly selective small molecule T-type calcium channel inhibitor designed to block neuronal bursting in the cerebello-thalamo-cortical circuit linked to tremor activity.

New ICD-10 diagnosis code is for patients with history of type 2 diabetes who bring blood sugar levels to a non-diabetic range below 6.5% for at least 3 months.

The HeroTracker Sense add-on device is compatible with several commonly prescribed ashtma and COPD medications.

Iptacopan, an oral factor B inhibitor, previously received accelerated approval in 2024 under the brand name Fabhalta for IgAN, specifically to reduce proteinuria in patients at risk of rapid disease ...

HealthDay News — After a 20-year absence, there were 10 cases of locally transmitted malaria in the US in 2023, according to a study published online October 6 in JAMA Network Open.

“Antibiotic resistance is widespread and threatening the future of modern medicine,” Dr Yvan Hutin, director of WHO’s Department of Antimicrobial Resistance, told The New York Times. “Simply put, the ...

Reports of local anesthetic poisonings decreased 2011 to 2022, but reports of lidocaine poisoning increased since 2010 advisories.

Patients with right heart failure due to pulmonary arterial hypertension should receive counseling and referral to center with expertise.

The ACHIEVE-5 trial (ClinicalTrials.gov identifier: NCT06109311) was a randomized, double-blind, placebo-controlled study that included 546 T2D patients with inadequate glycemic control on insulin ...

Evidence seen, however, for harmful effects from serious adverse events and several nonserious adverse events.

The triple therapy inhaler delivers 3 active ingredients: beclomethasone dipropionate, an inhaled corticosteroid, formoterol fumarate, a long-acting beta-agonist, and glycopyrrolate, an ...

Improvements in cause-specific and overall survival seen for those residing in rural and high-poverty communities.